Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Mental Health

Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study

Light therapy was found to have and early onset of action. On the HAM-D6 and the MES citalopram significantly reduced the relapse rate in the continuation phase.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors tested whether citalopram, an antidepressant, prevents relapse compared with placebo in 282 people with seasonal affective disorder who had responded to one week of light therapy. Over a 15-week continuation phase, citalopram was significantly better than placebo on two depression scales (HAM-D6 and Melancholia Scale), but not on the others.

Participants
282
Who or what was studied
Patients with Seasonal Affective Disorder (SAD) who responded to 1 week of light therapy
Limits stated in the abstract
The abstract reports differences as statistically significant on only two of four scales, and it does not describe the study's design details or follow-up beyond the 15-week continuation phase.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Placebo-controlled, Statistical significance, Depression, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Mental Health

Second-generation antidepressants for seasonal affective disorder

Evidence for the effectiveness of SGAs is limited to one small trial of fluoxetine compared with placebo, which shows a non-significant effect in favour of fluoxetine, and two small trials comparing fluoxetine against light therapy, which suggest equivalence between the two interventions.

Review · December 7, 2011 · Thaler K et al.